Comparison of intravenous ketorolac at three doses for treating renal colic in the emergency department: A noninferiority randomized controlled trial

Lily Eidinejad, Maryam Bahreini, Ayat Ahmadi, Mahtab Yazdchi, Venkatesh Thiruganasambandamoorthy, Hadi Mirfazaelian, Lily Eidinejad, Maryam Bahreini, Ayat Ahmadi, Mahtab Yazdchi, Venkatesh Thiruganasambandamoorthy, Hadi Mirfazaelian

Abstract

Background: Ketorolac tromethamine is a nonsteroidal anti-inflammatory drug (NSAID) that is extensively used for the management of renal colic in the emergency department (ED). It has been proposed that ketorolac is used at doses above its analgesic ceiling with no more advantages and increased risk of adverse effects. In this study, we compared the analgesic effects of three doses of intravenous ketorolac in patients with renal colic.

Methods: This noninferiority, randomized, double-blind clinical trial evaluated the analgesic efficacy of three doses of intravenous ketorolac (10, 20, and 30 mg) in adult patients presenting to the ED with renal colic. Exclusion criteria consisted of age > 65 years, active peptic ulcer disease, acute gastrointestinal hemorrhage, renal or hepatic insufficiency, NSAID hypersensitivity, pregnancy or breastfeeding, unstable vital signs, and patients who had received analgesics in the past 24 hours. Pain was recorded every 15 minutes from baseline up to 60 minutes, and the primary outcome was pain reduction at 30 minutes. If patients still required additional pain medications at 30 minutes, they would receive 0.1 mg/kg intravenous morphine sulfate as a rescue analgesic.

Results: A total of 165 subjects enrolled in this study, 55 in each group. The median visual analog scale score in 30 minutes was improved from 90 at baseline to 40 among subjects who were randomized to 30-mg group. This improvement was 40 and 50 mm in 20- and 10-mg ketorolac treatment arms, respectively, with no significant difference between the three doses (p < 0.05). Secondary outcomes showed similar rescue analgesic administration and adverse effects. There was no serious adverse event.

Conclusion: Ketorolac at 10-, 20-, and 30-mg doses can produce similar analgesic efficacy in renal colic.

Trial registration: ClinicalTrials.gov NCT03665753.

© 2020 by the Society for Academic Emergency Medicine.

References

REFERENCES

    1. Vadivelu N, Gowda AM, Urman RD, et al. Ketorolac tromethamine - routes and clinical implications. Pain Pract. 2015;15:175-193.
    1. Motov S, Yasavolian M, Likourezos A, et al. Comparison of intravenous ketorolac at three single-dose regimens for treating acute pain in the emergency department: a randomized controlled trial. Ann Emerg Med. 2017;70:177-184.
    1. Maslin B, Lipana L, Roth B, Kodumudi G, Vadivelu N. Safety considerations in the use of ketorolac for postoperative pain. Curr Drug Saf. 2017;12:67-73.
    1. Vadivelu N, Chang D, Helander EM, et al. Ketorolac, oxymorphone, tapentadol, and tramadol: a comprehensive review. Anesthesiol Clin. 2017;35:e1-e20.
    1. Rodriguez LA, Cattaruzzi C, Troncon MG, Agostinis L. Risk of hospitalization for upper gastrointestinal tract bleeding associated with ketorolac, other nonsteroidal anti-inflammatory drugs, calcium antagonists, and other antihypertensive drugs. Arch Intern Med. 1998;158:33-39.
    1. Di Trolio RN, Sing RF, Bates GM. Use of ketorolac in renal colic. J Am Osteopathic Assoc. 1999;99:589-590.
    1. Larsen LS, Miller A, Allegra JR. The use of intravenous ketorolac for the treatment of renal colic in the emergency department. Am J Emerg Med. 1993;11:197-199.
    1. Shrestha SK, Parajuli S, Nyaupane SP, Joshi HN. Study on acute renal colic and comparison of diclofenac and ketorolac in pain management in University Hospital, Kavre, Nepal. Kathmandu Univ Med J (KUMJ). 2019;17:35-39.
    1. Stein A, Ben Dov D, Finkel B, Mecz Y, Kitzes R, Lurie A. Single-dose intramuscular ketorolac versus diclofenac for pain management in renal colic. Am J Emerg Med. 1996;14:385-387.
    1. Sotoodehnia M, Farmahini-Farahani M, Safaie A, Rasooli F, Baratloo A. Low-dose intravenous ketamine versus intravenous ketorolac in pain control in patients with acute renal colic in an emergency setting: a double-blind randomized clinical trial. Korean J Pain 2019;32:97-104.
    1. Cordell W, Wright S, Wolfson A, et al. Comparison of intravenous ketorolac, meperidine, and both (balanced analgesia) for renal colic. Ann Emerg Med. 1996;28:151-158.
    1. Forouzanfar MM, Mohammadi K, Hashemi B, Safari S. Comparison of intravenous ibuprofen with intravenous ketorolac in renal colic pain management; a clinical trial. Anesthesiol Pain Med. 2019;9:e86963.
    1. Food and Drug Administration. Toradol® oral (ketorolac tromethamine tablets). Roche Laboratories Inc, 2013. . Accessed May 4, 2020.
    1. Duttchen KM, Lo A, Walker A, et al. Intraoperative ketorolac dose of 15mg versus the standard 30mg on early postoperative pain after spine surgery: a randomized, blinded, non-inferiority trial. J Clin Anesth. 2017;41:11-15.
    1. Olsen MF, Bjerre E, Hansen MD, et al. Pain relief that matters to patients: systematic review of empirical studies assessing the minimum clinically important difference in acute pain. BMC Med. 2017;15:35.
    1. Bijur PE, Chang AK, Esses D, Gallagher EJ. Identifying the minimum clinically significant difference in acute pain in the elderly. Ann Emerg Med. 2010;56(5):517-521.e1.
    1. Gallagher EJ, Liebman M, Bijur PE. Prospective validation of clinically important changes in pain severity measured on a visual analog scale. Ann Emerg Med. 2001;38:633-638.
    1. Jalili M, Entezari P, Doosti-Irani A, Masoomi R, Mirfazaelian H. Desmopressin effectiveness in renal colic pain management: systematic review and meta-analysis. Am J Emerg Med. 2016;34:1535-1541.
    1. Pedersen KV, Liao D, Osther SS, Drewes AM, Gregersen H, Osther PJ. Distension of the renal pelvis in kidney stone patients: sensory and biomechanical responses. Urol Res. 2012;40:305-316.
    1. Jalili M, Shirani F, Entezari P, Hedayatshodeh M, Baigi V, Mirfazaelian H. Desmopressin/indomethacin combination efficacy and safety in renal colic pain management: a randomized placebo controlled trial. Am J Emerg Med. 2019;37:1009-1012.
    1. Motov S, Fassassi C, Drapkin J, et al. Comparison of intravenous lidocaine/ketorolac combination to either analgesic alone for suspected renal colic pain in the ED. Am J Emerg Med. 2020;38(2):165-172.
    1. Holdgate A, Pollock T. Systematic review of the relative efficacy of non-steroidal anti-inflammatory drugs and opioids in the treatment of acute renal colic. BMJ. 2004;328:1401.
    1. Larkin GL, Peacock WF IV, Pearl SM, Blair GA, D'Amico F. Efficacy of ketorolac tromethamine versus meperidine in the ED treatment of acute renal colic. Am J Emerg Med. 1999;17:6-10.
    1. Holdgate A, Pollock T. Nonsteroidal anti-inflammatory drugs (NSAIDs) versus opioids for acute renal colic. Cochrane Database Syst Rev. 2004;(1):CD004137.
    1. Teichman JM. Acute renal colic from ureteral calculus. N Engl J Med. 2004;350:684-693.
    1. Soleyman-Zomalan E, Motov S, Likourezos A, Cohen V, Pushkar I, Fromm C. Patterns of ketorolac dosing by emergency physicians. World J Emerg Med. 2017;8:43.
    1. Hernández-Dı́az S, Garcı́a-Rodrı́guez LA. Epidemiologic assessment of the safety of conventional nonsteroidal anti-inflammatory drugs. Am J Med. 2001;110(3):20-27.
    1. Reuben SS, Connelly NR, Lurie S, Klatt M, Gibson CS. Dose-response of ketorolac as an adjunct to patient-controlled analgesia morphine in patients after spinal fusion surgery. Anesth Analg. 1998;87:98-102.
    1. Duttchen KM, Lo A, Walker A, et al. Intraoperative ketorolac dose of 15 mg versus the standard 30 mg on early postoperative pain after spine surgery: a randomized, blinded, non-inferiority trial. J Clin Anesth. 2017;41:11-15.
    1. Brown CR, Moodie JE, Wild VM, Bynum LJ. Comparison of intravenous ketorolac tromethamine and morphine sulfate in the treatment of postoperative pain. Pharmacotherapy. 1990;10:116S-S121.
    1. Staquet MJ. A double-blind study with placebo control of intramuscular ketorolac tromethamine in the treatment of cancer pain. J Clin Pharmacol. 1989;29:1031-1036.
    1. Minotti V, Betti M, Ciccarese G, Fumi G, Tonato M, Del Favero A. A double-blind study comparing two single-dose regimens of ketorolac with diclofenac in pain due to cancer. Pharmacotherapy. 1998;18:504-508.
    1. Bahreini M, Jalili M, Moradi-Lakeh M. A comparison of three self-report pain scales in adults with acute pain. J Emerg Med. 2015;48:10-18.

Source: PubMed

Sponsors en medewerkers

Medische omstandigheden

Geneesmiddelinterventies

3
Abonneren